The differences in immunogenicity of TP53 mutated endometrial-, high-grade serous ovarian- and triple negative breast carcinomas

被引：0
|
作者：
Zeimet, A. G. [1 ]
Leitner, K. [1 ]
Hackl, H. [2 ]
Fiegl, H. [1 ]
Feroz, B. [1 ]
Marth, C. [1 ]
Steger, K. [1 ]
机构：
[1] Med Univ Innsbruck, Gynecol & Obstet, Innsbruck, Austria
[2] Med Univ Innsbruck, Inst Bioinformat, Innsbruck, Austria
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.2152
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
792P
引用
收藏
页码：S591 / S591
页数：1
相关论文
共 50 条
  • [31] TP53 mutations and the association with platinum resistance in high grade serous ovarian carcinoma
    Montemorano, Lauren
    Shultz, Zoey B.
    Farooque, Alma
    Hyun, Meredith
    Chappell, Richard J.
    Hartenbach, Ellen M.
    Lang, Jessica D.
    GYNECOLOGIC ONCOLOGY, 2024, 186 : 26 - 34
  • [32] Immunohistochemistry in the Differential Diagnosis of High-Grade Serous and Triple Negative Breast Carcinomas: Old and New Markers
    Jain, Pragya Virendrakumar
    Molina, Mariel
    Moh, Michelle
    Bishop, Erin
    Rader, Janet
    Jorns, Julie
    LABORATORY INVESTIGATION, 2023, 103 (03) : S665 - S666
  • [33] TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer
    Chien, Jeremy
    Sicotte, Hugues
    Fan, Jian-Bing
    Humphray, Sean
    Cunningham, Julie M.
    Kalli, Kimberly R.
    Oberg, Ann L.
    Hart, Steven N.
    Li, Ying
    Davila, Jaime I.
    Baheti, Saurabh
    Wang, Chen
    Dietmann, Sabine
    Atkinson, Elizabeth J.
    Asmann, Yan W.
    Bell, Debra A.
    Ota, Takayo
    Tarabishy, Yaman
    Kuang, Rui
    Bibikova, Marina
    Cheetham, R. Keira
    Grocock, Russell J.
    Swisher, Elizabeth M.
    Peden, John
    Bentley, David
    Kocher, Jean-Pierre A.
    Kaufmann, Scott H.
    Hartmann, Lynn C.
    Shridhar, Viji
    Goode, Ellen L.
    NUCLEIC ACIDS RESEARCH, 2015, 43 (14) : 6945 - 6958
  • [34] TP53 Mutations in Circulating Cell-Free DNA as Longitudinal Biomarker for High-Grade Serous Ovarian Cancer
    Vitale, S. R.
    Groenendijk, F. H.
    Beaufort, C.
    Helmijr, J.
    Dubbink, H. J.
    Atmodimedjo, P.
    van Marion, R.
    Dinjens, W. N. M.
    Ewing-Graham, P. C.
    van Doorn, H. C.
    Berns, E. M. J. J.
    Boere, I. A.
    Helleman, J.
    Jansen, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (03): : S10 - S11
  • [35] Potent immunogenicity in BRCA1-mutated patients with high-grade serous ovarian carcinoma
    Dai, Ying
    Sun, Chengdu
    Feng, Yi
    Jia, Qingzhu
    Zhu, Bo
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (08) : 3979 - 3986
  • [36] Type of TP53 mutation is not prognostic in high grade serous ovarian carcinoma, but presence is prognostic in endometriosis-associated carcinomas
    Brett, Mary Anne
    Ramus, Susan
    Brenton, James
    Kobel, Martin
    LABORATORY INVESTIGATION, 2019, 99
  • [37] Type of TP53 mutation is not prognostic in high grade serous ovarian carcinoma, but presence is prognostic in endometriosis-associated carcinomas
    Brett, Mary Anne
    Ramus, Susan
    Brenton, James
    Kobel, Martin
    MODERN PATHOLOGY, 2019, 32
  • [38] "Triple hit" SOX11-, MME+, TP53 mutated high-grade pleomorphic mantle cell lymphoma
    Jain, Preetesh
    Tang, Guilin
    Li, Shaoying
    Wang, Michael
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (01) : 165 - 166
  • [39] Correlation of p53 Immunohistochemical Expression with TP53 Mutation in Extrauterine High-Grade Serous Carcinoma
    Karim, Lina Abdul
    Yang, Richard
    Ramalingam, Preetha
    Lawson, Barrett
    Malpica, Anais
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 639 - 640
  • [40] Correlation of p53 Immunohistochemical Expression with TP53 Mutation in Extrauterine High-Grade Serous Carcinoma
    Karim, Lina Abdul
    Yang, Richard
    Ramalingam, Preetha
    Lawson, Barrett
    Malpica, Anais
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 639 - 640
12345